How has Relay Therapeutics, Inc.'s customer receivables and other changed year-over-year?

Relay Therapeutics, Inc.'s customer receivables and other decreased by 31.5% year-over-year, from $7.81M to $5.35M.

What is the long-term trend for Relay Therapeutics, Inc.'s customer receivables and other?

Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s customer receivables and other has grown at a 138.9% compound annual growth rate (CAGR), from $830K to $27.04M.

Relay Therapeutics, Inc. RLAY Customer receivables and Other

Customer receivables and Other at other companies

Morgan StanleyMS

$2.52B+0.4%

KEE

Keel Infrastructure Corp. Common StockKEEL

$134.75K+48.1%

Raymond James FinancialRJF

$1.81B-3.5%

Chicago Atlantic Real Estate FinanceREFI

$2.56M+388%

Arbor Realty TrustABR

$35.25M+267%

Ares Management CorporationARES

$0-100%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.8B+300%

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s customer receivables and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s customer receivables and other?: Relay Therapeutics, Inc. (RLAY) reported customer receivables and other of $5.35M in Q1 2026.
How has Relay Therapeutics, Inc.'s customer receivables and other changed year-over-year?: Relay Therapeutics, Inc.'s customer receivables and other decreased by 31.5% year-over-year, from $7.81M to $5.35M.
What is the long-term trend for Relay Therapeutics, Inc.'s customer receivables and other?: Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s customer receivables and other has grown at a 138.9% compound annual growth rate (CAGR), from $830K to $27.04M.